On the contrary, however, astrocytes derived from iPSCs obtained from AD patients exert beneficial effects on Tau-exposed iPSCs-derived neurons by releasing matrix metalloproteinases (MMPs) [152]. The gene discussed is MAPT; the disease is Alzheimer disease.